Expression of estrogen-metabolizing enzymes and estrogen receptors in cholelithiasis gallbladder

Biomedicine and Pharmacotherapy

Volumn 62, Issue 10, 2008, Pages 690-696

  Svoboda, Martin ^a   Sellner, Franz ^c   Ekmekcioglu, Cem ^a   Klimpfinger, Martin ^c   Jaeger, Walter ^b   Thalhammer, Theresia ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Institute of Pathology and Bacteriology   (Austria)

Author keywords

Cholelithiasis; Estrogen receptor; Estrogen sulfotransferase; Gallbladder; Inflammation; Steroid sulfatase

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN SULFOTRANSFERASE; MESSENGER RNA; PROTEIN SULT1E1; STERYL SULFATASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CHOLELITHIASIS; CYTOSOL; ENZYME ACTIVITY; FEMALE; GALLBLADDER MUCOSA; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOLOGY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; CHOLELITHIASIS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GALLBLADDER; HUMANS; MALE; MIDDLE AGED; RNA, MESSENGER; STERYL-SULFATASE; SULFOTRANSFERASES;

EID: 56249109432     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.03.007     Document Type: Article

References (39)

1. Shaffer E.A. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 20 (2006) 981-996
2. Novacek G. Gender and gallstone disease. Wien Med Wochenschr 156 (2006) 527-533
3. Wang H.H., Afdhal N.H., and Wang D.Q. Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice. J Lipid Res 47 (2006) 778-786
4. Wang H.H., Afdhal N.H., and Wang D.Q. Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones. Gastroenterology 127 (2004) 239-249
5. Cirillo D.J., Wallace R.B., Rodabough R.J., Greenland P., LaCroix A.Z., Limacher M.C., et al. Effect of estrogen therapy on gallbladder disease. J Am Med Assoc 293 (2005) 330-339
6. Dahlman-Wright K., Cavailles V., Fuqua S.A., Jordan V.C., Katzenellenbogen J.A., Korach K.S., et al. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 58 (2006) 773-781
7. Wintermantel T.M., Campbell R.E., Porteous R., Bock D., Grone H.J., Todman M.G., et al. Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron 52 (2006) 271-280
8. Gustafsson J.A. What pharmacologists can learn from recent advances in estrogen signalling. Trends Pharmacol Sci 24 (2003) 479-485
9. Alvaro D., Gigliozzi A., and Attili A.F. Regulation and deregulation of cholangiocyte proliferation. J Hepatol 33 (2000) 333-340
10. Ranelletti F.O., Piantelli M., Farinon A.M., Zanella E., and Capelli A. Estrogen and progesterone receptors in the gallbladders from patients with gallstones. Hepatology 14 (1991) 608-612
11. Yamamoto M., Nakajo S., and Tahara E. Immunohistochemical analysis of estrogen receptors in human gallbladder. Acta Pathol Jpn 40 (1990) 14-21
12. Sumi K., Matsuyama S., Kitajima Y., and Miyazaki K. Loss of estrogen receptor beta expression at cancer front correlates with tumor progression and poor prognosis of gallbladder cancer. Oncol Rep 12 (2004) 979-984
13. Pettersson K., Grandien K., Kuiper G.G., and Gustafsson J.A. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol 11 (1997) 1486-1496
14. Weyant M.J., Carothers A.M., Mahmoud N.N., Bradlow H.L., Remotti H., Bilinski R.T., et al. Reciprocal expression of ERalpha and ERbeta is associated with estrogen-mediated modulation of intestinal tumorigenesis. Cancer Res 61 (2001) 2547-2551
15. Cho N.L., Javid S.H., Carothers A.M., Redston M., and Bertagnolli M.M. Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res 67 (2007) 2366-2372
16. Keus F., Broeders I.A., and van Laarhoven C.J. Gallstone disease: surgical aspects of symptomatic cholecystolithiasis and acute cholecystitis. Best Pract Res Clin Gastroenterol 20 (2006) 1031-1051
17. Sanders G., and Kingsnorth A.N. Gallstones. BMJ 335 (2007) 295-299
18. Tazuma S., and Kajiyama G. Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones. Langenbecks Arch Surg 386 (2001) 224-229
19. Tiwari-Woodruff S., Morales L.B., Lee R., and Voskuhl R.R. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci U S A 104 (2007) 14813-14818
20. Bukulmez O., Hardy D.B., Carr B.R., Word R.A., and Mendelson C.R. Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology 149 (2008) 1190-1204
21. Sanchez-Archidona A.R., Jimenez M.A., Perez-Alenza D., Silvan G., Illera J.C., Pena L., et al. Steroid pathway and oestrone sulphate production in canine inflammatory mammary carcinoma. J Steroid Biochem Mol Biol 104 (2007) 93-99
22. Nowell S., and Falany C.N. Pharmacogenetics of human cytosolic sulfotransferases. Oncogene 25 (2006) 1673-1678
23. Sasano H., Suzuki T., Nakata T., and Moriya T. New development in intracrinology of breast carcinoma. Breast Cancer 13 (2006) 129-136
24. Pasqualini J.R. Progestins and breast cancer. Gynecol Endocrinol 23 Suppl. 1 (2007) 32-41
25. Iwamori M. Estrogen sulfatase. Meth Enzymol 400 (2005) 293-302
26. Selcer K.W., Difrancesca H.M., Chandra A.B., and Li P.K. Immunohistochemical analysis of steroid sulfatase in human tissues. J Steroid Biochem Mol Biol 105 (2007) 115-123
27. Miettinen M., Isomaa V., Peltoketo H., Ghosh D., and Vihko P. Estrogen metabolism as a regulator of estrogen action in the mammary gland. J Mammary Gland Biol Neoplasia 5 (2000) 259-270
28. Falany C.N. Sulfation and sulfotransferases. Introduction: changing view of sulfation and the cytosolic sulfotransferases. FASEB J 11 (1997) 1-2
29. Falany J.L., and Falany C.N. Regulation of estrogen activity by sulfation in human MCF-7 breast cancer cells. Oncol Res 9 (1997) 589-596
30. Lakehal F., Wendum D., Barbu V., Becquemont L., Poupon R., Balladur P., et al. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium. Hepatology 30 (1999) 1498-1506
31. Rost D., Konig J., Weiss G., Klar E., Stremmel W., and Keppler D. Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia. Gastroenterology 121 (2001) 1203-1208
32. Aust S., Obrist P., Jaeger W., Klimpfinger M., Tucek G., Wrba F., et al. Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium. Lab Invest 84 (2004) 1024-1036
33. Laatikainen T. Excretion of neutral steroid hormones in human bile. Ann Clin Res 2 Suppl (1970) 1-28
34. Tanaka S., Tanaka H., Yamamoto T., Shuto T., Takemura S., Hai S., et al. Immunohistochemical demonstration of c-Kit protooncogene product in gallbladder cancer. J Hepatobiliary Pancreat Surg 13 (2006) 228-234
35. Suzuki T., Nakata T., Miki Y., Kaneko C., Moriya T., Ishida T., et al. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res 63 (2003) 2762-2770
36. Smuc T., Rupreht R., Sinkovec J., Adamski J., and Rizner T.L. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer. Mol Cell Endocrinol 248 (2006) 114-117
37. Chadwick C.C., Chippari S., Matelan E., Borges-Marcucci L., Eckert A.M., Keith Jr. J.C., et al. Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity. Proc Natl Acad Sci U S A 102 (2005) 2543-2548
38. Perwez Hussain S., and Harris C.C. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121 (2007) 2373-2380
39. Risbridger G.P., Ellem S.J., and McPherson S.J. Estrogen action on the prostate gland: a critical mix of endocrine and paracrine signaling. J Mol Endocrinol 39 (2007) 183-188